Hamilelik ve Emzirme Döneminde Baş Ağrıları ve Tedavi Yaklaşımı
Özet
Gebelik ve emzirme döneminde primer ve sekonder baş ağrılarının doğru tanı ve tedavisi, hem anne hem de fetus sağlığı açısından büyük önem taşımaktadır. Doğurganlık çağında sık görülen migren ve gerilim tipi baş ağrısı gibi primer ağrılar hormonal dalgalanmalarla tetiklenebilmektedir. Tedavi yaklaşımında öncelikle tetikleyicilerden kaçınma, düzenli beslenme, uyku ve gevşeme egzersizleri gibi farmakolojik olmayan yöntemler tercih edilmelidir. İlaç tedavisinde akut ataklar için asetaminofen gebelikte ve emzirmede en güvenli birinci basamak seçenektir. NSAİİ'lerden ilk trimesterde düşük riskini, geç dönemde ise duktus arteriyozusun erken kapanması gibi ciddi fetal komplikasyonları artırması nedeniyle kaçınılmalıdır. Triptanlar arasında sumatriptan, antiemetiklerden ise metoklopramid gebelikte ilk seçenek olarak öne çıkmaktadır. Şiddetli vakalarda profilaksi amacıyla en düşük dozda beta-blokerler tercih edilebilirken, antiepileptikler ve ACE inhibitörleri teratojenik etkilerinden dolayı kontrendikedir. Magnezyum sülfat ve periferik sinir blokları güvenli alternatifler sunmaktadır. Hayatı tehdit edebilecek preeklampsi, PRES ve serebral venöz sinüs trombozu gibi sekonder nedenler ise kırmızı bayrak belirtileriyle titizlikle ayırt edilmelidir.
Accurate diagnosis and treatment of primary and secondary headaches during pregnancy and lactation are of great importance for both maternal and fetal health. Primary headaches such as migraine and tension-type headache, which are common in childbearing age, can be triggered by hormonal fluctuations. In the treatment approach, non-pharmacological methods such as avoiding triggers, regular diet, sleep, and relaxation exercises should be preferred first. In drug treatment, acetaminophen is the safest first-line option for acute attacks during pregnancy and lactation. NSAIDs should be avoided as they increase the risk of miscarriage in the first trimester and serious fetal complications such as premature closure of the ductus arteriosus in the late period. Among triptans, sumatriptan stands out as the first choice during pregnancy, and metoclopramide among antiemetics. While low-dose beta-blockers may be preferred for prophylaxis in severe cases, antiepileptics and ACE inhibitors are contraindicated due to their teratogenic effects. Magnesium sulfate and peripheral nerve blocks offer safe alternatives. Secondary causes of headache that can be life-threatening, such as preeclampsia, PRES, and cerebral venous sinus thrombosis, must be meticulously differentiated by red flag symptoms.
Referanslar
Marcus DA. Managing headache during pregnancy and lactation. Expert Rev. Neurotherapeutics 2008; 8 (3): 385-395.
Robbins MS. Headache and Pregnancy. Continuum (Minneap Minn). 2018;24(4):1092-1107.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd ed. Cephalalgia 2013; 33(9):629-808.
Chen TC, Leviton A. Headache recurrences in pregnant women with migraine. Headache 1994; (34): 107-110.
Melhado EM, Maciel JA, Guerreiro CM. Headache during gestation: evaluation of 1101 women. Can. J. Neurol. Sci 2007; (34): 187-192.
Calhoun AH. Migraine Treatment in Pregnancy and Lactation. Curr Pain Headache Rep 2017;21 (11):46.
Cupini LM, Matteis M, Troisi E, et al. Sex-hormone-related events in migrainous females. A clinical comperative study between migraine with aura and migraine without aura. Cephalalgia 1995;12(2):140-144.
Amundsen S, Øvrebø TG, Amble NM, et al. Use of antimigraine medications and information needs during pregnancy and breastfeeding: a crosssectional study among 401 Norwegian women. Eur J Clin Pharmacol 2016;72(12):1525–1535.
Granella F, Sances G, Pucci E, et al. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000;20(8):701–707.
Olesen J, Goadsby PJ, Ramadan NM, et al.,(2006). The Headaches. 3rd ed. Philadelphia: Williams & Wilkins.
Macgregor EA. Headache in pregnancy. Continuum (Minneap Minn) 2014;20 (1 Neurology of Pregnancy):128–147.
Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, femalehormones, sleep pattern and relation to lifestyle. Pain 1993;53(1):65–72.
Marcus DA, Scharff L, Turk DC. Nonpharmacological management of headaches during pregnancy. Psychosom Med 1995;57(6):527–535.
Yılmaz E, Çevik IU. Headache in challenging and special circumstances: Pregnancy and lactation. Agri 2018;30(4):153-164.
Nezvalová-Henriksen K, Spigset O, Nordeng H. Maternal characteristics and migraine pharmacotherapy during pregnancy: cross-sectionalanalysis of data from a large cohort study. Cephalalgia 2009;29(12):1267–1276.
Brandlistuen RE, Ystrom E, Nulman I, et al. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohortstudy. Int J Epidemiol 2013;42(6):1702–1713.
Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr 2014;168(4):313–320.
Thompson JM, Waldie KE, Wall CR, et al; ABC study group. Associations between acetaminophen use during pregnancy and ADHD symptoms measuredat ages 7 and 11 years. PLoS One 2014;9(9):e108210.
Amundsen S, Nordeng H, Nezvalová-Henriksen K, et al. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol 2015;11(4):209–219.
Bitzén PO, Gustafsson B, Jostell KG, et al. Excretion of paracetamol in human breast milk. Eur J Clin Pharmacol 1981;20(2):123–125.
Davanzo R, Bua J, Paloni G, et al. Breastfeeding and migraine drugs. Eur J Clin Pharmacol 2014;70(11):1313–1324.
Worthington I, Pringsheim T, Gawel MJ, et al. Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian Headache Society Guideline: acute drug therapy for migraine headache. Can J Neurol Sci 2013;40(5 Suppl 3):S1–S80.
Koren G, Florescu A, Costei AM, et al. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closureof the ductus arteriosus: a meta-analysis. Ann Pharmacother 2006;40(5):824–829.
Reese J, Paria BC, Brown N, et al. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc Natl Acad Sci U S A 2000;97(17):9759–9764.
Hernandez RK, Werler MM, Romitti P, et al. National Birth Defects Prevention Study. Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol 2012;206(3):228.e1–8.
Nakhai-Pour HR, Broy P, Sheehy O, et al. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ 2011;183(15):1713–1720.
Norton ME, Merrill J, Cooper BA, et al. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329(22):1602–1607.
Tyler CP, Paneth N, Allred EN, et al. ELGAN Study Investigators. Brain damage in preterm newborns and maternal medication: the ELGAN Study. Am J Obstet Gynecol 2012;207(3):192.e1–9.
Benini D, Fanos V, Cuzzolin L, et al. In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol 2004;19(2):232–234.
Alano MA, Ngougmna E, Ostrea EM Jr, et al. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistentpulmonary hypertension of the newborn. Pediatrics 2001;107(3):519–523.
Cassina M, Di Gianantonio E, Toldo I, et al. Migraine therapy during pregnancy and lactation. Expert Opin Drug Saf 2010;9(6):937–948.
Gupta S, Hanff LM, Visser W, et al. Functional reactivity of 5-HT receptors in human umbilical cord and maternal subcutaneous fat arteries after normotensive or pre-eclamptic pregnancy. J Hypertens 2006;24(7):1345–53.
Soldin OP, Dahlin J, O’Mara DM. Triptans in pregnancy. Ther Drug Monit 2008;30(1):5–9.
Hale TW (2006). Medications and Mothers’ Milk. 12th ed. Hale Publishing;.
Pasternak B, Svanström H, Mølgaard-Nielsen D, et al. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA 2013;310(15):1601–11.
Kathryn K Collins, Judith M Sondheimer. Domperidone-induced QT prolongation: add another drug to the list. J Pediatr (2008);153(5):596-598.
Shannon ME, Malecha SE, Cha AJ. Beta blockers and lactation: an update. J Hum Lact 2000;16(3):240–245.
Evers S, Afra J, Frese A, et al. European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol 2009;16(9):968–981.
Mines D, Tennis P, Curkendall SM, et al. Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf 201;23(10):1017–1025.
Banach R, Boskovic R, Einarson T, et al. Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies. Drug Saf 2010;33(1):73–79.
Hägg S, Spigset O. Anticonvulsant use during lactation. Drug Saf 2000;22(6):425–440.
Pringsheim T, Davenport W, Mackie G, et al. Canadian Headache Society Prophylactic Guidelines Development Group. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci 2012;39(2):S1–59.
Bullo M, Tschumi S, Bucher BS, et al. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension 2012;60(2):444–450.
Walfisch A, Al-maawali A, Moretti ME, et al. Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.J Obstet Gynaecol. 2011;31(6):465-472.
Tan M, Kim E, Koren G, et al. Botulinum toxin type A in pregnancy. Can Fam Physician 2013;59(11):1183–1184.
Yamasaki M. Magnesium and pregnancy. [Article in Japanese]. Clin Calcium 2012;22(8):1205–1210.
Demirkaya S, Vural O, Dora B, et al. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 2001;41(2):171–177.
Blumenfeld A, Ashkenazi A, Napchan U, et al. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative review. Headache 2013;53(3):437–446.
Nau H. Clinical pharmacokinetics in pregnancy and perinatology. I. Placental transfer and fetal side effects of local anaesthetic agents. Dev Pharmacol Ther 1985;8(3):149–181.
Govindappagari S, Grossman TB, Dayal AK, et al. Peripheral nerve blocks in the treatment of migraine in pregnancy. Obstet Gynecol 2014;124(6):1169–1174.
Bendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol 2010;17(11):1318–1325.
Jürgens TP, Schaefer C, May A. Treatment of cluster headache in pregnancy and lactation. Cephalalgia 2009;29(4):391–400.
Robbins MS, Farmakidis C, Dayal AK, et al. Acute headache diagnosis in pregnant women: a hospital-based study. Neurology 2015; 85 (12): 1024-1030.
Burch R. Headache in Pregnancy and Puerperium. Neurol Clin 2019 (37): 31-51.
